ATE462413T1 - Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln - Google Patents

Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln

Info

Publication number
ATE462413T1
ATE462413T1 AT01902059T AT01902059T ATE462413T1 AT E462413 T1 ATE462413 T1 AT E462413T1 AT 01902059 T AT01902059 T AT 01902059T AT 01902059 T AT01902059 T AT 01902059T AT E462413 T1 ATE462413 T1 AT E462413T1
Authority
AT
Austria
Prior art keywords
agent
particles
mixture
drug
macromolecular
Prior art date
Application number
AT01902059T
Other languages
German (de)
English (en)
Inventor
Edith Mathiowitz
Yong Jong
Jules Jacob
Original Assignee
Univ Brown Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brown Res Found filed Critical Univ Brown Res Found
Application granted granted Critical
Publication of ATE462413T1 publication Critical patent/ATE462413T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01902059T 2000-01-14 2001-01-12 Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln ATE462413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17619300P 2000-01-14 2000-01-14
PCT/US2001/001183 WO2001051032A2 (en) 2000-01-14 2001-01-12 Micronized freeze-dried particles

Publications (1)

Publication Number Publication Date
ATE462413T1 true ATE462413T1 (de) 2010-04-15

Family

ID=22643372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902059T ATE462413T1 (de) 2000-01-14 2001-01-12 Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln

Country Status (7)

Country Link
EP (1) EP1246609B1 (enExample)
JP (1) JP2003519651A (enExample)
AT (1) ATE462413T1 (enExample)
AU (1) AU773735B2 (enExample)
CA (1) CA2397404C (enExample)
DE (1) DE60141680D1 (enExample)
WO (1) WO2001051032A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809309B1 (fr) * 2000-05-23 2004-06-11 Mainelab Microspheres a liberation prolongee pour administration injectable
CA2456806C (en) 2001-08-08 2011-10-18 Brown University Research Foundation Methods for micronization of hydrophobic drugs
AU2002360549A1 (en) * 2001-12-10 2003-06-23 Spherics, Inc. Methods and products useful in the formation and isolation of microparticles
JP4679822B2 (ja) * 2002-03-13 2011-05-11 ノバルティス アーゲー 医薬微粒子
SI21222A (sl) * 2002-05-28 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo nanodelcev
US7670627B2 (en) * 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
JP2006199589A (ja) * 2003-09-03 2006-08-03 Ltt Bio-Pharma Co Ltd 生理活性タンパク質またはペプチドを含有するナノ粒子およびその製造方法、ならびに当該ナノ粒子からなる外用剤
WO2006088647A1 (en) * 2005-02-17 2006-08-24 Medivas, Llc Polymer particle delivery compositions and methods of use
JP4755992B2 (ja) * 2003-12-19 2011-08-24 アルク−アベッロ エイ／エス 有効医薬成分の寒冷顆粒化及び貯蔵の方法
AU2004298719B8 (en) 2003-12-19 2011-04-07 Alk-Abello A/S Cryogranulation and storage method for active pharmaceutical agents
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
EP2026771B1 (en) * 2006-01-23 2009-10-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Microspheres comprising nanocapsules containing a lipophilic drug
CA2957966C (en) * 2014-08-14 2021-11-30 Brown University Compositions for stabilizing and delivering proteins
CN108379243A (zh) * 2018-03-22 2018-08-10 福州大学 一种载基因多孔磁性微球的制备方法
CN115005320B (zh) * 2022-05-07 2023-09-05 中国农业大学 一种具有长效饱腹感的酪蛋白粉的制备方法及所得产物
CN116982619A (zh) * 2023-08-04 2023-11-03 洛阳奇泓生物科技有限公司 丙交酯-Nisin固体分散体及其制备

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798755B2 (ja) * 1985-11-27 1995-10-25 エチコン・インコ−ポレ−テツド 局所的投与により術後の癒着形成を抑制するための組成物
DE3779221D1 (de) * 1986-08-19 1992-06-25 Genentech Inc Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
AU714584B2 (en) * 1995-07-21 2000-01-06 Brown University Research Foundation A method for gene therapy using nucleic acid loaded polymeric microparticles
EP0889722B1 (en) * 1996-03-28 2002-11-20 Takeda Chemical Industries, Ltd. Sustained-release preparation and its production
EP0975334B1 (en) * 1997-04-17 2003-10-22 Amgen Inc., Biodegradable microparticles for the sustained delivery of therapeutic drugs
JP3918248B2 (ja) * 1997-09-26 2007-05-23 ソニー株式会社 固体撮像素子およびその駆動方法

Also Published As

Publication number Publication date
JP2003519651A (ja) 2003-06-24
EP1246609A2 (en) 2002-10-09
CA2397404C (en) 2008-12-02
CA2397404A1 (en) 2001-07-19
AU773735B2 (en) 2004-06-03
DE60141680D1 (de) 2010-05-12
AU2790201A (en) 2001-07-24
WO2001051032A2 (en) 2001-07-19
EP1246609B1 (en) 2010-03-31
WO2001051032A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ATE462413T1 (de) Verfahren zur herstellung von mikronisierte gefriergetrocknete partikeln
Gómez-Mascaraque et al. Electrosprayed gelatin submicroparticles as edible carriers for the encapsulation of polyphenols of interest in functional foods
CN1232411A (zh) 用超临界流体进行微囊包封的方法
DE3382587D1 (de) Injizierbares langwirkendes mikroteilchen-praeparat zur verabreichung entzuendungshemmender mittel.
GR3018939T3 (en) Method for producing protein microspheres
EP0625069A1 (de) Verfahren zur herstellung von mikrokapseln
ATE277601T1 (de) Verbesserungen bezüglich der verkapselung bioaktiver wirkstoffe
DE69415684T2 (de) Verfahren zur herstellung von mikrospharen mit einer wirbelschichtstufe
JPH0687758A (ja) Ｌｈｒｈホルモンおよびその類似体を徐々に放出する微小球体の製造方法と、その微小球体と、それを含む製剤
JP5373618B2 (ja) 微粒化方法
SK87493A3 (en) Pancreatin micropellets
DE502006005846D1 (de) Verfahren zur schonenden herstellung hochfeiner partikelsuspensionen und hochfeiner partikel sowie deren verwendung
DE60030999D1 (de) Verfahren zur herstellung von teilchen
Yang et al. Phenyl groups in supramolecular nanofibers confer hydrogels with high elasticity and rapid recovery
JP2017522394A5 (enExample)
IE58245B1 (en) Micro-encapsulation of medicaments
JP2009513165A5 (enExample)
Hsein et al. Atomization of denatured whey proteins as a novel and simple way to improve oral drug delivery system properties
US6482518B1 (en) Excipient for the lyophilization of aqueous suspensions of microparticles
CY1113221T1 (el) Διεργασια για την παρασκευη ενος φαρμακου
CN116803382B (zh) 一种曲安奈德缓释微球、制备方法及曲安奈德缓释制剂
Symecko et al. Binder functionality in tabletted systems
JP2017520593A (ja) 微小インスリン、微小インスリン類似体及びそれらの製造方法
TW200502039A (en) Process for the preparation of catalyst microspheres
KR20110060257A (ko) 하이드로겔 가교체를 형성하여 효소를 안정화시키는 방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties